Paragraph IV Disputes Master Symposium
American Conference Institute
Oct
2
2017
Date: October 2, 2017 - October 3, 2017
Time: 5:00AM - 1:00PM
Location: Chicago, Illinois
Topics
- Ethics Lab for Paragraph IV Practice: Identifying and Avoiding Ethics Pitfalls in Hatch-Waxman Litigation
- Novartis v. Noven – A Study in Obvious Contrasts: Dilemmas Associated with Different Standards of Review
Event Details
ACI’s industry-leading Paragraph IV Disputes Master Symposium enters its fifth iteration this fall. This event will pick up where ACI Paragraph IV conference left off to bring you up-to-the minute information on the latest developments affecting ANDA litigation.
Preeminent patent litigators representing brand name and generic drug makers, leading in-house counsel, and esteemed jurists will provide insights on such matters as:
- The impact of TC Heartland on jurisdiction and venue
- The legal and business repercussions of Helsinn
- Amgen v. Sandoz from an ANDA litigator’s point of view
- The FDA Final MMA Rule
- Novartis v. Noven and differing standards of review
- Secondary considerations in obviousness reviews
- Alternative forums: PTAB and ITC
- Oil States vs. Greene’s Energy Group and the constitutionality of IPR proceedings
- Exceptional case findings
- Reverse payment settlements
- Patent lawsuit risk assessment and other IP due diligence essentials
Speakers
Speaker